Literature DB >> 14991516

An Aeromonas veronii biovar sobria infection with disseminated intravascular gas production.

Yukio Shiina1, Kunio Ii, Masaaki Iwanaga.   

Abstract

We report a case of Aeromonas veronii biovar sobria infection with disseminated intravascular gas production. The patient was an afebrile 15-year-old girl who had been quite healthy until the onset of the illness. She came to the hospital because of a 6-h history of increasing pain and swelling in her left thigh. On admission, no infection was suspected, and a tentative diagnosis of a ruptured left gracilis muscle was made. Because the pain increased continuously, the treatment concentrated on pain control. Unexpectedly, abrupt death occurred 23 h after her admission. Postmortem computed tomographic (CT) scans showed an abundance of gas in the blood vessels of the entire body. Postmortem investigation revealed disseminated intravascular gas production, marked intravascular hemolysis, and numerous intravascular Gram-negative bacilli in all organs examined. The organisms were identified as A. veronii biovar sobria, and were highly susceptible to third-generation cephalosporins. Regarding therapeutic problems, the early administration of these antibiotics should reduce the fatality rate in such infections. It is critical to keep the possibility of such an infection in mind when a patient complains of severe muscle pain.

Entities:  

Mesh:

Year:  2004        PMID: 14991516     DOI: 10.1007/s10156-003-0274-2

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  2 in total

1.  Suicide plasmid-dependent IS1-element untargeted integration into Aeromonas veronii bv. sobria generates brown pigment-producing and spontaneous pelleting mutant.

Authors:  Said Kamal Abolghait
Journal:  Curr Microbiol       Date:  2013-02-23       Impact factor: 2.188

2.  Distribution of Aeromonas species in environmental water used in daily life in Okinawa Prefecture, Japan.

Authors:  Kazufumi Miyagi; Itaru Hirai; Kouichi Sano
Journal:  Environ Health Prev Med       Date:  2016-04-13       Impact factor: 3.674

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.